AIM ImmunoTech, Inc. (AIM)
0.3967
+0.16
(+70.48%)
USD |
NYAM |
May 27, 15:32
AIM ImmunoTech Free Cash Flow : -11.67M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agenus, Inc. | -87.53M |
| Curis, Inc. | -28.95M |
| Plus Therapeutics, Inc. | -21.72M |
| Windtree Therapeutics, Inc. | -15.12M |
| Halozyme Therapeutics, Inc. | 667.65M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.719M |
| Cash from Investing (Quarterly) | -0.037M |
| Cash from Financing (Quarterly) | 5.587M |
| Free Cash Flow Per Share (Quarterly) | -0.6329 |
| Free Cash Flow to Equity (Quarterly) | -2.432M |
| Free Cash Flow to Firm (Quarterly) | -2.45M |
| Free Cash Flow Yield | -1.14K% |